imidazole-2-hydroxybenzoate has been researched along with 6-ketoprostaglandin f1 alpha in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badalamenti, S; Chinea, B; Lorenzano, E; Salerno, F; Scaricabarozzi, I; Scotti, A | 1 |
1 trial(s) available for imidazole-2-hydroxybenzoate and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Renal effects of imidazole-2-hydroxybenzoate in patients with compensated liver cirrhosis.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Female; Humans; Imidazoles; Kidney; Kidney Function Tests; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; p-Aminohippuric Acid; Pilot Projects; Renal Circulation; Salicylates | 1992 |